CooperCompanies Appoints Cynthia Lucchese to Board of Directors
Retrieved on:
Monday, October 3, 2022
Workforce, The Cooper Companies, Guidant, Trustee, Board of directors, Lucchese, Fertility, Audit committee, Thoratec, CEO, Health, Hulman, Boston Scientific, Business administration, Committee, Corporate governance, CA, Association of Corporate Treasurers, Cooper, Genomics, Accounting, CooperVision, NYSE, SAN, Penske Corporation, Hulman & Company, Eli Lilly and Company, Master of Business Administration, Board, Woman, Bachelor of Science, Finance, GLOBE, Management, Company, Science, Indiana University
SAN RAMON, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) announced today that its Board of Directors has appointed Cynthia Lucchese as an independent director, effective October 1, 2022.
Key Points:
- SAN RAMON, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) announced today that its Board of Directors has appointed Cynthia Lucchese as an independent director, effective October 1, 2022.
- Lucchese has also been appointed to serve on the Audit Committee and Corporate Governance and Nominating Committee when she joins the Board.
- We are pleased to welcome Cindy to Coopers Board of Directors, said Al White, President and CEO of CooperCompanies.
- Lucchese serves on the Boards of Directors of Inari Medical Inc. and Beaver-Visitec International Holdings.